<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Twenty-nine patients aged 62-82 years with <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) were treated with a 21-day course of continuous infusion <z:chebi fb="0" ids="28680">cytarabine</z:chebi>, oral <z:chebi fb="0" ids="44423">hydroxyurea</z:chebi>, and 1,25-dihydroxyvitamin D3 (<z:chebi fb="0" ids="17823">calcitriol</z:chebi>) </plain></SENT>
<SENT sid="1" pm="."><plain>Ten patients had an antecedent <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="17823">Calcitriol</z:chebi> was continued as the only postremission therapy </plain></SENT>
<SENT sid="3" pm="."><plain>Thirteen patients (45%) obtained a complete remission, and 10 patients (34%) had a partial response for an overall 79% response rate </plain></SENT>
<SENT sid="4" pm="."><plain>There were three early <z:hpo ids='HP_0011420'>deaths</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The median remission duration was 9.8 months </plain></SENT>
<SENT sid="6" pm="."><plain>Overall median survival was 12 months for <z:hpo ids='HP_0000001'>all</z:hpo> patients and 14 months for responding patients </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> responding patients had marked <z:hpo ids='HP_0005528'>bone marrow hypoplasia</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Twenty patients received part or <z:hpo ids='HP_0000001'>all</z:hpo> of their chemotherapy as outpatients </plain></SENT>
<SENT sid="9" pm="."><plain>This regimen has acceptable toxicity and can result in prolonged remissions in elderly, high-risk patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>The favorable results may be related to the synergistic effect of <z:chebi fb="0" ids="44423">hydroxyurea</z:chebi>, <z:chebi fb="0" ids="28680">cytarabine</z:chebi>, and <z:chebi fb="0" ids="17823">calcitriol</z:chebi> </plain></SENT>
</text></document>